Skip to main content
Clinical Trials/CTRI/2023/09/057542
CTRI/2023/09/057542
Recruiting
Phase 3

Randomised controlled clinical trial of efficacy of Munditika churna and Haritaki churna in the management of Vatarakta (gout) - NI

Pathan Md Junaid Naim Khan0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Pathan Md Junaid Naim Khan
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pathan Md Junaid Naim Khan

Eligibility Criteria

Inclusion Criteria

  • 1\. Participants having classical sign \& symptoms of Vatarakta like \- 1\. Shotha (Swelling)
  • 2\. Kathinya (Stiffness \& Hardness)
  • 3\. Vedanadhikya (Severe pain)
  • 4\. Daha (Burning sensation)
  • 5\. Toda (Pricking pain)
  • 6\. Shyavata \& tamrata (Blackish or Coppery)
  • 7\. Sphurana (Twitching sensation)
  • 8\. Participants having age group between 18 years to 60 years
  • 9\. Participants having Serum Uric acid level \> 7 mg/dl in Males \& \>6 mg/dl in Females
  • 10\. Participants will be selected irrespective Gender, Religion, Socio\-Economic status

Exclusion Criteria

  • 1\. Participants having complications like Paka, Khanja, Pangulya and Sandhi vakrata will be excluded.
  • 2\. Alcohol and drug abusers, Pregnant and lactating women
  • 3\. Symptomatic participants with clinical evidence of Kidney failure
  • 4\. k/c/o Malignancy, poorly controlled DM, HTN
  • 5\. Participants having other acute or complicated systemic disease which require long term drug treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials